Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
出版年份 2017 全文链接
标题
Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
作者
关键词
Cancer treatment, Cervical cancer, Condyloma acuminata, Swaziland, Human papillomavirus infection, Health economics, Lesions, Cancer screening
出版物
PLoS One
Volume 12, Issue 5, Pages e0177762
出版商
Public Library of Science (PLoS)
发表日期
2017-05-23
DOI
10.1371/journal.pone.0177762
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland
- (2017) Themba G. Ginindza et al. PLoS One
- Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
- (2016) Eva Herweijer et al. INTERNATIONAL JOURNAL OF CANCER
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
- (2015) Ellinor Östensson et al. PLoS One
- Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
- (2014) Eva Herweijer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
- (2014) Mark Jit et al. Lancet Global Health
- Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program
- (2013) Ellinor Östensson et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Health and Economic Burden of HPV-related Diseases in Singapore
- (2012) Jeffrey Jen Hui Low et al. Asian Pacific Journal of Cancer Prevention
- Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study
- (2012) Ju-Fang Shi et al. BMC HEALTH SERVICES RESEARCH
- Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus
- (2012) T. Bärnighausen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Economic Burden of Human Papillomavirus-Related Diseases in Italy
- (2012) Gianluca Baio et al. PLoS One
- Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
- (2012) Harrell W. Chesson et al. VACCINE
- Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa
- (2011) Nicole G. Campos et al. INTERNATIONAL JOURNAL OF CANCER
- Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale
- (2011) Wilm Quentin et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Economic burden of HPV-related cancers in France
- (2011) I. Borget et al. VACCINE
- Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel
- (2011) Oren Shavit et al. Applied Health Economics and Health Policy
- Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China
- (2010) Carol E. Levin et al. INTERNATIONAL JOURNAL OF CANCER
- Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium
- (2010) Lieven Annemans et al. JOURNAL OF MEDICAL ECONOMICS
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
- (2009) Marie-Pierre David et al. GYNECOLOGIC ONCOLOGY
- The economic burden of noncervical human papillomavirus disease in the United States
- (2008) Delphine Hu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study
- (2008) Peter Hillemanns et al. BMC INFECTIOUS DISEASES
- Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age
- (2008) Diane M. Harper GYNECOLOGIC ONCOLOGY
- Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
- (2008) Arthi Vijayaraghavan et al. GYNECOLOGIC ONCOLOGY
- Age for HPV vaccination
- (2008) Diane M. Harper et al. VACCINE
- Mathematical Models of Cervical Cancer Prevention in the Asia Pacific Region
- (2008) Sue J. Goldie et al. VACCINE
- Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
- (2008) Tino F. Schwarz et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More